日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy

接受伊布替尼治疗的慢性淋巴细胞白血病患者的细胞对Axl受体酪氨酸激酶抑制剂治疗敏感。

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.26444
Sinha, Sutapa; Boysen, Justin C; Chaffee, Kari G; Kabat, Brian F; Slager, Susan L; Parikh, Sameer A; Secreto, Charla R; Call, Tim; Shanafelt, Tait D; Leis, Jose F; Warner, Steven L; Bearss, David J; Ghosh, Asish K; Kay, Neil E
白血病
信号转导
细胞生物学
发表日期：2018
文献求助 收藏

Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study

Akt抑制剂MK-2206联合苯达莫司汀和利妥昔单抗治疗复发或难治性慢性淋巴细胞白血病：N1087联盟研究结果

期刊:American Journal of Hematology
影响因子:9.9
doi:10.1002/ajh.24762
Larsen, Jeremy T; Shanafelt, Tait D; Leis, Jose F; LaPlant, Betsy; Call, Tim; Pettinger, Adam; Hanson, Curtis; Erlichman, Charles; Habermann, Thomas Matthew; Reeder, Craig; Nikcevich, Daniel; Bowen, Deborah; Conte, Michael; Boysen, Justin; Secreto, Charla; Lesnick, Connie; Tschumper, Renee; Jelinek, Diane; Kay, Neil E; Ding, Wei
细胞生物学
白血病
发表日期：2017
文献求助 收藏

Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia

每日口服多酚E治疗无症状Rai分期0至II期慢性淋巴细胞白血病患者的I期临床试验

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2008.21.1284
Shanafelt, Tait D; Call, Tim G; Zent, Clive S; LaPlant, Betsy; Bowen, Deborah A; Roos, Michelle; Secreto, Charla R; Ghosh, Asish K; Kabat, Brian F; Lee, Mao-Jung; Yang, Chung S; Jelinek, Diane F; Erlichman, Charles; Kay, Neil E
白血病
细胞生物学
发表日期：2009
文献求助 收藏

Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia.

治疗前血管生成细胞因子可预测慢性淋巴细胞白血病患者对化疗免疫疗法的反应

期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/j.1365-2141.2009.07811.x
Shanafelt Tait D, Byrd John C, LaPLant Betsy, Zent Clive S, Call Tim, Secreto Charla, Grever Michael R, Lin Thomas S, Kay Neil E
细胞生物学
白血病
血管生成
发表日期：2009
文献求助 收藏

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential

CD49d表达是慢性淋巴细胞白血病患者总生存期的独立预测因子：具有治疗潜力的预后参数。

期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/j.1365-2141.2007.06965.x
Shanafelt, Tait D; Geyer, Susan M; Bone, Nancy D; Tschumper, Renee C; Witzig, Tom E; Nowakowski, Greg S; Zent, Clive S; Call, Tim G; Laplant, Betsy; Dewald, Gordon W; Jelinek, Diane F; Kay, Neil E
白血病
细胞生物学
T细胞
CD4
发表日期：2008
文献求助 收藏

MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?

MBL 或 CLL：哪种分类最能恰当地描述绝对淋巴细胞计数 ≥ 5 x 10(9) L(-1) 但 B 细胞淋巴细胞计数 <5 x 10(9) L(-1) 的患者的临床病程？

期刊:Leukemia Research
影响因子:2.2
doi:10.1016/j.leukres.2007.11.030
Shanafelt, Tait D; Kay, Neil E; Call, Tim G; Zent, Clive S; Jelinek, Diane F; LaPlant, Betsy; Morice, William G; Hanson, Curtis A
T细胞
细胞生物学
发表日期：2008
文献求助 收藏